The Oncology Institute is involved in providing value-based oncology care. The Oncology Institute, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK.
| Revenue (Most Recent Fiscal Year) | $502.73M |
| Net Income (Most Recent Fiscal Year) | $-60.61M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.70 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -12.08% |
| Net Margin (Trailing 12 Months) | -11.45% |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -33.70% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.59 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.35 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 26.71 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-0.16 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.06 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.54 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.56 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Common Shares Outstanding | 98.84M |
| Free Float | 90.44M |
| Market Capitalization | $349.89M |
| Average Volume (Last 20 Days) | 1.48M |
| Beta (Past 60 Months) | 0.17 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 8.50% |
| Percentage Held By Institutions (Latest 13F Reports) | 36.86% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |